Nucleic acid-based therapies such as DNA and siRNA has equipped us with the freedom to customize in our battle against specific cancers and other diseases. Especially the non-viral approach to deliver the therapeutic nucleic acids in a clinical setting provides a safer alternative to the viral gene therapy systems. However, to achieve a clinically relevant […]
Read More